Hypoxia‐inducible factor‐2α directly promotes <i><scp>BCRP</scp></i> expression and mediates the resistance of ovarian cancer stem cells to adriamycin
Miao He(He University), Minjie Wei(China Medical University)
Cited by 58
Related Papers
HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways
|Journal of Experimental & Clinical Cancer Research|2018|156
Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2′-O-methylation via NOP58 recruitment in colorectal cancer
|Molecular Cancer|2020|154
A novel HIF-2α targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI/GPR78-UPRER axis
|Cell Death and Differentiation|2022|92
Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer
|Journal for ImmunoTherapy of Cancer|2023|76
SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway
|Journal of Translational Medicine|2019|72